Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions

被引:90
作者
Ketchedjian, A
Jones, AL
Krueger, P
Robinson, E
Crouch, K
Wolfinbarger, L
Hopkins, R
机构
[1] Brown Univ, Collis Cardiac Surg Lab, Dept Cardiothorac Surg, Providence, RI 02912 USA
[2] LifeNet Tissue Serv, Virginia Beach, VA USA
关键词
D O I
10.1016/j.athoracsur.2004.09.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Decellularized allograft tissues have been identified as a potential extracellular matrix (EM scaffold on which to base recellularized tissue-engineered vascular and valvular substitutes. Decreased antigenicity and the capacity to recellularize suggest that such constructs may have favorable durability. Detergent/enzyme decellularization methods remove cells and cellular debris while leaving intact structural protein "scaffolds." Allograft pulmonary artery tissues decellularized with an anionic detergent/enzyme methodology were tested in a long-term implantation model that used arterial wall repairs in the great vessels of juvenile sheep. Methods. Twelve test sheep were implanted (n = 4) for each of three different scaffold protocols that compared traditional dimethylsulfoxide cryopreservation, cryopreservation followed by decellularization, and decellularization of fresh tissue. Four additional sheep served as controls In = 2 sham, n = 2 fresh tissue). Patches were fashioned and implanted into pulmonary artery and measured over time (10 to 20 weeks). Explant histopathology determined recellularization morphology as well as calcium, collagen, and elastin distribution within explanted tissue. Results. Unlike traditionally cryopreserved tissues, the decellularized tissues contained no residual cells or cellular debris before implantation, which correlated with measurable reductions in PRA. Decellularized explants demonstrated time-dependent migration of recipient cells through matrix, typically staining positive for a-smooth muscle actin with no calcification. Conclusions. The properties demonstrated seem consistent with characteristics necessary for implantable tissue-engineered scaffolds. The decellularization method described appears to create a biologically suitable ECM scaffold for in vivo migration of phenotypically appropriate cells while avoiding antigenicity and calcification.
引用
收藏
页码:888 / 896
页数:9
相关论文
共 23 条
  • [1] The immunogenicity of the extracellular matrix in arterial xenografts
    Allaire, E
    Bruneval, P
    Mandet, C
    Becquemin, JP
    Michel, JB
    [J]. SURGERY, 1997, 122 (01) : 73 - 81
  • [2] Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity?
    Baskett, RJ
    Ross, DB
    Nanton, MA
    Murphy, DA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05) : 1170 - 1178
  • [3] Blood group incompatibility and accelerated homograft fibrocalcifications
    Christenson, JT
    Vala, D
    Sierra, J
    Beghetti, M
    Kalangos, A
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (01) : 242 - 250
  • [4] Dignan R, 2003, J HEART VALVE DIS, V12, P382
  • [5] IMMUNOLOGICAL REACTION AND VIABILITY OF CRYOPRESERVED HOMOGRAFTS
    FISCHLEIN, T
    SCHUTZ, A
    HAUSHOFER, M
    FREY, R
    UHLIG, A
    DETTER, C
    REICHART, B
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (02) : S122 - S126
  • [6] Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts
    Hawkins, JA
    Hillman, ND
    Lambert, LM
    Jones, J
    Di Russo, GB
    Profaizer, T
    Fuller, TC
    Minich, LL
    Williams, RV
    Shaddy, RE
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (01) : 247 - 253
  • [7] Allograft heart valves: The role of apoptosis-mediated cell loss
    Hilbert, SL
    Luna, RE
    Zhang, J
    Wang, Y
    Hopkins, RA
    Yu, ZX
    Ferrans, VJ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (03) : 454 - 462
  • [8] Hilbert SL, 2004, J HEART VALVE DIS, V13, P831
  • [9] Donor-specific cellular immune response against human cardiac valve allografts
    Hoekstra, F
    Knoop, C
    Vaessen, L
    Wassenaar, C
    Jutte, N
    Bos, E
    Bogers, A
    Weimar, W
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (02) : 281 - 286
  • [10] Hoekstra F, 1997, J HEART LUNG TRANSPL, V16, P570